{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:57:02Z","timestamp":1778201822175,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.revmed.2012.01.014","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T21:55:54Z","timestamp":1330034154000},"page":"364-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Atteintes ORL de la maladie de Fabry\u00a0: \u00e0 propos de 25\u00a0observations"],"prefix":"10.1016","volume":"33","author":[{"given":"M.","family":"Pichon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Lidove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-L.","family":"Roudaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Gobert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pasqualoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Compain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-P.","family":"Chauveheid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Papo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2012.01.014_bib0005","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2012.01.014_bib0010","series-title":"The metabolic and molecular bases of inherited disease","article-title":"Alpha galactosidase A deficiency: Fabry disease","author":"Desnick","year":"1995"},{"key":"10.1016\/j.revmed.2012.01.014_bib0015","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/GIM.0b013e3181f13b75","article-title":"Effects of enzyme replacement therapy in Fabry disease - a comprehensive review of the medical literature","volume":"12","author":"Lidove","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.revmed.2012.01.014_bib0020","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98\u00a0hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.revmed.2012.01.014_bib0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2350-3-10","article-title":"Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients","volume":"3","author":"Germain","year":"2002","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.revmed.2012.01.014_bib0030","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60\u00a0obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.revmed.2012.01.014_bib0035","article-title":"Fabry disease \u2018The New Great Imposter\u2019: results of the French observatoire in internal medicine departments (FIMeD)","author":"Lidove","year":"2011","journal-title":"Clin Genet"},{"issue":"Pt 1","key":"10.1016\/j.revmed.2012.01.014_bib0040","first-page":"143","article-title":"Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease","volume":"130","author":"Ries","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2012.01.014_bib0045","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1023\/B:BOLI.0000009948.86528.72","article-title":"Hearing loss in Fabry disease: the effect of agalsidase alfa replacement therapy","volume":"26","author":"Hajioff","year":"2003","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.revmed.2012.01.014_bib0050","article-title":"Atteintes ORL de la maladie de Fabry\u00a0: \u00e0 propos de 25\u00a0observations","volume":"32","author":"Pichon","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.01.014_bib0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.0307-7772.2001.00464.x","article-title":"Hearing evaluation with distortion - product otoacoustic emissions in young patients undergoing haemodialysis","volume":"26","author":"Stavroulaki","year":"2001","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.revmed.2012.01.014_bib0060","first-page":"491","article-title":"The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency) - investigation of symptomatic and presymptomatic patients","volume":"75","author":"Morgan","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/j.revmed.2012.01.014_bib0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1651-2227.2003.tb00219.x","article-title":"Auditory and vestibular findings in Fabry disease: a study of hemizygous males and heterozygous females","volume":"92","author":"Conti","year":"2003","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.revmed.2012.01.014_bib0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.2003.tb00220.x","article-title":"Head-impulse testing in Fabry disease-vestibular function in male and female patients","volume":"92","author":"Palla","year":"2003","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.revmed.2012.01.014_bib0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s101620010060","article-title":"Caloric and search-coil head-impulse testing in patients after vestibular neuritis","volume":"2","author":"Schmid-Priscoveanu","year":"2001","journal-title":"J Assoc Res Otolaryngol"},{"issue":"Suppl. 2","key":"10.1016\/j.revmed.2012.01.014_bib0080","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1016\/S0248-8663(10)70022-9","article-title":"Vestibular and cochlear manifestations in Fabry's disease","volume":"31","author":"Malinvaud","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.01.014_bib0085","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00415-007-0575-y","article-title":"Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy","volume":"254","author":"Palla","year":"2007","journal-title":"J Neurol"},{"issue":"148","key":"10.1016\/j.revmed.2012.01.014_bib0090","article-title":"Bilateral perceptive hearing loss: immunological or vascular mechanism? Prospective study of 28\u00a0cases","volume":"12","author":"Lidove","year":"2001","journal-title":"Eur J Intern Med"},{"issue":"Suppl. 1","key":"10.1016\/j.revmed.2012.01.014_bib0095","article-title":"Analyse multivari\u00e9e d\u2019une cohorte de 108\u00a0patients porteurs de la maladie de Fabry. Observatoire fran\u00e7ais m\u00e9decine interne - Maladie de Fabry","volume":"32","author":"Kaminsky","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.01.014_bib0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/toxsci\/kfq267","article-title":"An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin","volume":"119","author":"Quiros","year":"2010","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.revmed.2012.01.014_bib0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0272-2712(18)30572-9","article-title":"Nephrotoxic and ototoxic agents","volume":"10","author":"Walker","year":"1990","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.revmed.2012.01.014_bib0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.1999.tb00278.x","article-title":"Insights into ototoxicity. Analogies to nephrotoxicity","volume":"884","author":"Humes","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2012.01.014_bib0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00868342","article-title":"Stroke in Fabry's disease","volume":"241","author":"Grewal","year":"1994","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2012.01.014_bib0120","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy","volume":"104","author":"Moore","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.revmed.2012.01.014_bib0125","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/01.STR.32.7.1559","article-title":"Enhanced endothelium-dependent vasodilation in Fabry disease","volume":"32","author":"Altarescu","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.revmed.2012.01.014_bib0130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jmg.38.9.629","article-title":"Non-invasive evaluation of arterial involvement in patients affected with Fabry disease","volume":"38","author":"Boutouyrie","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.revmed.2012.01.014_bib0135","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00415-004-0364-9","article-title":"Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease","volume":"251","author":"Hilz","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2012.01.014_bib0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","article-title":"Profile of endothelial and leukocyte activation in Fabry patients","volume":"47","author":"De Graba","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2012.01.014_bib0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410400105","article-title":"Cerebrovascular complications of Fabry's disease","volume":"40","author":"Mitsias","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2012.01.014_bib0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00005792-199801000-00002","article-title":"Susac syndrome","volume":"77","author":"Papo","year":"1998","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2012.01.014_bib0155","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","article-title":"A phase 1\/2\u00a0clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies","volume":"68","author":"Eng","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.revmed.2012.01.014_bib0160","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2012.01.014_bib0165","first-page":"87","article-title":"Inner ear involvement in Anderson-Fabry disease: long-term follow-up during enzyme replacement therapy","volume":"30","author":"Sergi","year":"2010","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.1016\/j.revmed.2012.01.014_bib0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000124297","article-title":"Hyperbaric oxygen treatment restores sudden hearing loss in a patient with Fabry disease","volume":"70","author":"Frantz","year":"2008","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.revmed.2012.01.014_bib0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2174\/1875397301004010050","article-title":"Fabry disease - current treatment and new drug development","volume":"4","author":"Motabar","year":"2010","journal-title":"Curr Chem Genomics"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866312000197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866312000197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:29:47Z","timestamp":1759336187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866312000197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0248866312000197"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2012.01.014","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atteintes ORL de la maladie de Fabry\u00a0: \u00e0 propos de 25\u00a0observations","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2012.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}